Bayer Aktiengesellschaft

Miles Inc.

Klaus Schaller

Manfred Plempel

Bernd Baasner

Hans-Otto Werling

Richard F Hector

Heinrich F Moeschler

Harald Labischinski

Hein-Peter Kroll

Rainer Endermann

Oswald Lockhoff

Reiner Fischer

Albrecht Marhold

Bernd Riedl

Hanno Wild

Andreas Stolle

Hans-Joachim Santel

Robert R Schmidt

Karl H Buchel

Klaus Lurssen

Hans-Ludwig Elbe

Benedikt Becker

Andreas Krebs

Dieter Habich

Klaus Dieter Bremm

Wilhelm Stendel

Karl G Metzger

Hans-Joachim Zeiler

Hermann Hagemann

Peter Stadler

Stephan Bartel

Thomas Himmler

Uwe Petersen

Bernd-Wieland Kruger

Thomas Jaetsch

Michael Matzke

Klaus G Stunkel

Helmut Brunner

Hans-Georg Opitz

Joachim Ippen

Thomas Schenke

Harry Strang

Erik Regel

Ernst Kysela

Burkhard Mielke

Miklos Von Bittera

Martin Ruppelt

Ulrike Wachendorff-Neumann

Wilhelm Brandes

Christoph Erdelen

Stefan Dutzmann

Paul Reinecke

Manfred Jautelat

Elisabeth Perzborn

Jorg Stetter

Graham Holmwood

Gunther Beck

Hermann Uhr

Arno Widdig

Friedel Seuter

Klaus-Dieter Bremm

Peter Andrews

Arnold Paessens

Walter Puls

Helmut Heitzer

Gert Streissle

Gerhard Zoebelein

Hans Zahner

Yutaka Hayauchi

Hartwig Holst

Dieter H Abich

Hans-Paul Hagenmaier

Volker Klimetzek

Thomas Sch&eacute;nke

Manfred Blempel

Hermann Hageman

Hannelore Drautz

Gerhard Werner

Magdalena Liszkay

Ehrhardt Proksch

The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives, which are substituted in the 7-position by a 2-oxa-5,8-diazabicyclo&lsqb;4.3.0&rsqb;-non-8-yl) radical, and their pharmaceutically utilizable hydrates and/or salts for the therapy of infections and the gastroduodenal disorders associated therewith.

USE OF 7-(2-OXA-5,8-DIAZABICYLCO&lsqb;4.3.0&rsqb;NON-8-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDON CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF HELIOBACTER PYLORI INFECTIONS AND ASSOCIATED GASTRODUODENAL DISEASES

The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in position 7 by a 1-aminomethyl-2-oxa-7-azabicyclo&lsqb;3.3.0&rsqb;oct-7-yl radical, and of their salts for the therapy of,infections and associated gastroduodenal disorders.

Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo&lsqb;3.3.0&rsqb;oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith

The invention relates to the use of substituted 2-aminothiazoles for promoting wound healing.

Use of aminothiazoles for treating wounds and skin

Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic

The invention relates to heteroatom-containing benzocyclopentaneoxazolidinones, to processes for their preparation and their use as medicaments, especially as antibacterial medicaments.

Heteroatom-containing benzocyclopentane-oxazolidinones

The present invention relates to (2-aminoacylamino-2-deoxy-glycosyl)-amides, which are substituted on the nitrogen atom of the amino acid, of the general formula (I) ##STR1## in which the substituents have the meaning given in the description, to processes for their preparation and to their use in medicaments.

Glycosyl-amides of 2-aminoacylamino-2-deoxy-sugars

Glycosylamides of 2-aminoacylamino-2-deoxy sugars

The invention relates to 6-membered nitrogen-containing heteroaryloxazolidinones, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.

6-membered nitrogen-containing heteroaryl-oxazolidinones

The present invention relates to 5-membered heteroaryl-oxazolidinones, to processes for their preparation and to their use as medicaments, in particular as antibacterial medicaments.

5-membered heteroaryl-oxazolidinones

The present invention relates to benzofuranyl- and benzothienyloxazolidinones, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.

Benzofuranyl -and benzothienyloxazolidinones

The invention relates to benzoxazolyl- and benzothiazolyloxazolidinones, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.

Benzoxazolyl- and benzothiazolyloxazolidinones

There are provided new substituted 3-aryl-pyrrolidine-2,4-diones of the formula ##STR1## in which X represents hydrogen, alkyl, halogen or alkoxy,

Substituted 3-aryl-pyrrolidine-2,4-diones

Nikkomycin compounds have been found to be orally or parenterally effective as anti-fungals in animals. They may be used alone or, preferably, in combination with azole antimycotics for a synergistic anti-fungal effect.

Antimycotic compositions of nikkomycin compounds and azole antimycotics

1-Trifluoromethyl-1-nitro-2-alkoxy-2-aryl-ethanes of the formula ##STR1## in which R.sup.1 represents a straight-chain or branched alkyl radical and

1-trifluoromethyl-1-nitro-2-alkoxy-2-aryl-ethanes, their preparation and

Growing community of inventors

Wuppertal, Germany

Klaus Schaller